Company / SG&A per Share
Tyra Biosciences, Inc. SG&A per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.42
FY2024
5-year range
$0.38 / $1.36
FY2020-FY2024
Trend
+3.2%
vs FY2023
Sector context
#176 of 210
Health Care
What the data says
Tyra Biosciences, Inc.'s sg&a per share of $0.42 is lower than 84% of companies in the Health Care sector (FY2024). Increased from $0.38 to $0.42 over the past 2 years.
Based on SEC 10-K filings.
0.42 in FY2024 with a 3-year CAGR of +0.9%.
Increased from $0.38 to $0.42 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +0.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 210This company $0.42 Sector average $40.75
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share increased 3.2% year-over-year.
- Ranks #176 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2020.
- Lowest sg&a per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.42 | +3.2% |
| FY2023 | $0.41 | +7.4% |
| FY2022 | $0.38 | -7.3% |
| FY2021 | $0.41 | -69.8% |
| FY2020 | $1.36 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026